Anti-cancer New Technology Breakthroughs Are Frequent, Biological Health Get Global Attention

An Australian cancer drug can effectively dissolve cancer cells and cure leukemia. According to the latest reports, the new drug for treatment of leukemia and other cancers had been approved by the U.S. Food and Drug Administration, and been officially marketed in the United states. Coincidentally, the recent Australia network reported that the first patient with leukemia accepting the world's most advanced CAR-T cell therapy has been confirmed to completely recover from leukemia. Therefore, whether it is cancer therapy, or cancer technology, there has been a leap forward in progress, as researchers developed virus-like particles with Ebola virus shell, but without the nucleic acid content, which also takes a key step in the vaccine and drug development.The new anticancer drug Venetoclax is jointly studied by scientists in Australia and the United States. The team used the "Venetoclax" (a small molecule Bcl-2 inhibitor. Bcl-2, a substance formed by protein synthesis that would prolong the survival of cancer cells) in cancer patients.The clinical trial of the new drug lasted for 4 years, and had shown good results in 116 patients, including Melbourne and the United States. Experiments showed that the new drugs can significantly reduce the number of leukemia cells.In addition, 79% of chronic lymphocytic leukemia (CLL) patients showed a positive reaction on the drug; another 20% previously treated patients were failed in the test, but there was no trace of cancer cells.In fact, Venetoclax is a cancer drug that was developed 30 years ago. 30 years repeated trials finally lead to the first time on the human body, and this life-saving medicine finally is listed. It is also the repeated experiments ensure the safety before large-scale production.The Venetoclax in the United States approved the listing, not only means that the medical profession on the efficacy of this new drug, but also makes so many patients obtain the hope to live.About the author: Creative Biostructure has developed custom MemPro™ gene-to-structure services for the SNARE complex. The superfamily of SNARE complex contains 3 families: SNARE complex, synaptobrevin and syntaxin. We offer insightful strategies and cost-effective services on structure determination of macromolecules using X-ray Crystallography, EM, NMR, etc.